Long-Term Outcomes of the Ovation Stent Graft System: Single-Center Experience
Journal of Clinical Medicine · 12.06.2025 · 14 (12) · 4177
DOI: 10.3390/jcm14124177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.06.2025. Verfasst von Gianluigi Fino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vascular and Endovascular Surgery Unit, S. Maria della Misericordia University Hospital, 06132 Perugia, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objective: To report mid-term to long-term outcome data for endovascular aortic repair using the Ovation stent graft system (Endologix, Santa Rosa, CA) for the correction of abdominal aortic aneurysms (AAAs) in a single center.
Methods
All patients treated with the Ovation stent graft between December 2011 and February 2018 were included. Patient demographics, anatomical and operative details, as well as follow- up data including complications, the need for further interventions, and mortality were recorded prospectively in an electronic dataset and analyzed.
Results
A total of 99 patients (86.10% males; mean age 73.6 ± 7.26 years) were treated with the Ovation stent graft. The mean maximal aortic diameter was 53.7 ± 8.8 mm mm. The main indications for Ovation use were small iliac accesses and thrombus/calcification at the proximal neck level. The technical success rate was 93.06%. No perioperative reintervention or limb occlusion was reported. Two graft-related perioperative adverse events were recorded. At a mean follow up of 82.70 ± 40 months, cumulative late survival was 97.90%, 92.60%, 81.00%, 73.40%, 48.70%, and 45.10%, respectively, at 12, 24, 48, 60, 108, and 120 months. No AAA-related death was recorded. Actuarial freedom from reintervention rate was 97.90%, 95.70%, 92.10%, and 80.10%, respectively, at 12, 24, 60, 108, and 120 months; estimated freedom from conversion was 98.90%, 97.70%, and 95.20% at 24, 60, 108, and 120 months.
Conclusions
The Ovation stent graft demonstrated durable AAA exclusion even in complex anatomies evidenced by successful aneurysm exclusion and mid- to long-term freedom from aneurysm-related mortality. However, in this series, the not insignificant graft-related adverse event rate suggested the need for structural improvements, which were implemented in the next-generation devices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular and Endovascular Surgery Unit, S. Maria della Misericordia University Hospital, 06132 Perugia, Italy.
ORCID-Profile: Gianluigi Fino, Enrico Cieri, Gioele Simonte
Zitieren
APA
Fino, G., Isernia, G., Parlani, G., Belardi, A., Del Mastro, F., Cieri, E., Lenti, M., & Simonte, G. (2025). Long-Term Outcomes of the Ovation Stent Graft System: Single-Center Experience. Journal of Clinical Medicine, 14(12), 4177. https://doi.org/10.3390/jcm14124177
Vancouver
Fino G, Isernia G, Parlani G, Belardi A, Del Mastro F, Cieri E, et al. Long-Term Outcomes of the Ovation Stent Graft System: Single-Center Experience. Journal of Clinical Medicine. 2025;14(12):4177. doi:10.3390/jcm14124177
BibTeX
@article{Fino2025,
author = {Fino, Gianluigi and Isernia, Giacomo and Parlani, Gianbattista and Belardi, Adriana and Del Mastro, Francescopio and Cieri, Enrico and Lenti, Massimo and Simonte, Gioele},
title = {Long-Term Outcomes of the Ovation Stent Graft System: Single-Center Experience},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {12},
pages = {4177},
doi = {10.3390/jcm14124177}
}
EUVIMED